| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.4 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.049 | 0.4 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |